Literature DB >> 30872848

Antimicrobial usage in western Canadian cow-calf herds.

Cheryl L Waldner1, Sarah Parker1, Sheryl Gow1, Devon J Wilson1, John R Campbell1.   

Abstract

While ongoing surveillance and research initiatives have provided some information on antimicrobial use (AMU) in many livestock commodities, there are no recent reports for Canadian cow-calf herds. Antimicrobial use data were collected in 2014 for bulls, cows, and calves from 100 herds participating in the Western Canadian Cow-Calf Surveillance Network. Lameness was the most common reason for treatment in cows and bulls, with oxytetracycline being the treatment of choice. Herd owners were most likely to treat calves before weaning with florfenicol, oxytetracycline, and sulfamethazine for respiratory disease or diarrhea. The most frequently reported reason for antimicrobial use in weaned calves was respiratory disease and the most reported product was florfenicol. While 98% of herds reported treating ≥ 1 animal with antimicrobials, most cattle did not receive antimicrobials for either treatment or disease prevention on participating cow-calf operations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30872848      PMCID: PMC6380250     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  6 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Antimicrobial use on 24 beef farms in Ontario.

Authors:  Carolee A Carson; Richard Reid-Smith; Rebecca J Irwin; Wayne S Martin; Scott A McEwen
Journal:  Can J Vet Res       Date:  2008       Impact factor: 1.310

3.  Constraint approaches to the estimation of relative risk.

Authors:  Yuanyuan Tang; Philip G Jones; Liangrui Sun; Suzanne V Arnold; John A Spertus
Journal:  Stat Methods Med Res       Date:  2017-04-13       Impact factor: 3.021

4.  Survey of western Canadian beef producers regarding calf-hood diseases, management practices, and veterinary service usage.

Authors:  Cheryl Waldner; Murray D Jelinski; Katelyn McIntyre-Zimmer
Journal:  Can Vet J       Date:  2013-06       Impact factor: 1.008

Review 5.  Antimicrobial usage and resistance in beef production.

Authors:  Andrew Cameron; Tim A McAllister
Journal:  J Anim Sci Biotechnol       Date:  2016-12-12

6.  Antimicrobial drug use and reason for treatment in 203 western Canadian cow-calf herds during calving season.

Authors:  Sheryl P Gow; Cheryl L Waldner
Journal:  Prev Vet Med       Date:  2009-04-19       Impact factor: 2.670

  6 in total
  4 in total

Review 1.  Bovine Respiratory Disease: Conventional to Culture-Independent Approaches to Studying Antimicrobial Resistance in North America.

Authors:  Sara Andrés-Lasheras; Murray Jelinski; Rahat Zaheer; Tim A McAllister
Journal:  Antibiotics (Basel)       Date:  2022-04-05

Review 2.  Antimicrobial Use and Resistance in Surplus Dairy Calf Production Systems.

Authors:  Poonam G Vinayamohan; Samantha R Locke; Rafael Portillo-Gonzalez; David L Renaud; Gregory G Habing
Journal:  Microorganisms       Date:  2022-08-16

3.  Comparative occurrence and antibiogram of extended-spectrum β-lactamase-producing Escherichia coli among post-weaned calves and lactating cows from smallholder dairy farms in a parallel animal husbandry area.

Authors:  Chya Vannakovida; Kannika Na Lampang; Phongsakorn Chuammitri; Veerasak Punyapornwithaya; Khwanchai Kreausukon; Raktham Mektrirat
Journal:  Vet World       Date:  2021-05-26

4.  Prevalence and Risk Factors Associated With Antimicrobial Resistance in Bacteria Related to Bovine Respiratory Disease-A Broad Cross-Sectional Study of Beef Cattle at Entry Into Canadian Feedlots.

Authors:  Sara Andrés-Lasheras; Reuben Ha; Rahat Zaheer; Catrione Lee; Calvin W Booker; Craig Dorin; Joyce Van Donkersgoed; Rob Deardon; Sheryl Gow; Sherry J Hannon; Steve Hendrick; Michele Anholt; Tim A McAllister
Journal:  Front Vet Sci       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.